Intrinsic Value of S&P & Nasdaq Contact Us

GlucoTrack, Inc. GCTK NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • IL • USD

SharesGrow Score
63/100
2/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

GlucoTrack, Inc. (GCTK) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Or Yehuda, Israel. The current CEO is Paul V. Goode.

GCTK has IPO date of 2013-04-25, 11 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $416.97K.

About GlucoTrack, Inc.

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

📍 8 Ariel Sharon Street, Or Yehuda 7760049 📞 972 8 675 7878
Company Details
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryIsrael
ExchangeNASDAQ Capital Marke
CurrencyUSD
IPO Date2013-04-25
CEOPaul V. Goode
Employees11
Trading Info
Current Price$0.73
Market Cap$416.97K
52-Week Range0.619-15.9
Beta0.35
ETFNo
ADRNo
CUSIP45824Q804
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message